MedTrace Logo

Characterization of Patients With Post-ischemic Left Ventricular Dysfunction

NCT04699565 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 303

Last updated 2023-10-04

No results posted yet for this study

Summary

This is an observational, prospective, multicenter study (12 hospitals belonging to the Italian Cardiology Network) in patients with STEMI ST elevation myocardial infarction (STEMI) treated successfully with primary percutaneous coronary intervention (PCI), that will be followed for 12 month after the acute event, in order to ascertain the predictive value of myocardial viability measured with cardiac magnetic resonance (1.5 T; based on the transmural distribution of late enhancement in the infarcted segments) for the identification of left ventricular (LV) remodelling (REM) 6 months after STEMI.

Conditions

  • Left Ventricular Diastolic Dysfunction

Interventions

DIAGNOSTIC_TEST

Cardiac magnetic resonance

Evaluate the predictive value of myocardial viability measured with cardiac magnetic resonance for the identification of LV REM 6 months after STEMI

Sponsors & Collaborators

  • IRCCS San Raffaele

    lead OTHER

Principal Investigators

  • Paolo Camici, MD, FACC · Ospedale San Raffaele

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-18
Primary Completion
2020-09-30
Completion
2021-04-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04699565 on ClinicalTrials.gov